Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
1995
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
2001 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma
2013
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
2014 Standout
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Combined chemokine and cytokine gene transfer enhances antitumor immunity
1996
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Immunotherapy for Epstein-Barr Virus-Associated Cancers
1998
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
1996
Biology and adoptive cell therapy of Epstein‐Barr virus‐associated lymphoproliferative disorders in recipients of marrow allografts
1997
Quantum dots versus organic dyes as fluorescent labels
2008 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders
2009
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Labelling of cells with quantum dots
2005
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
1996 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro
1995
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA
1998
Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging
2000
Adenoviral Vectors Expressing Lymphotactin and Interleukin 2 or Lymphotactin and Interleukin 12 Synergize to Facilitate Tumor Regression in Murine Breast Cancer Models
1999
An Improved Method for Generating Retroviral Producer Clones for Vectors Lacking a Selectable Marker Gene
1998
Gene Marking
1996
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
1996
Acute Myeloid Leukemia and the Position of Autologous Stem Cell Transplantation
2007
High-Efficiency Transduction and Long-Term Gene Expression with a Murine Stem Cell Retroviral Vector Encoding the Green Fluorescent Protein in Human Marrow Stromal Cells
1999
Graft-versus-host disease
2009 Standout
Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells
1998
In vivo selection of retrovirally transduced hematopoietic stem cells
1998
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Autografting in chronic myeloidleukaemia
1994
Bone Marrow Transplantation
1994
Childhood Leukemias
1995
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
1997 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
1996
Acute Myeloid Leukemia
1999
Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell
2001 Standout
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Inhibition of Papillomavirus Protein Function in Cervical Cancer Cells by Intrabody Targeting
2005 StandoutNobel
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
Epstein–Barr Virus Infection
2000 Standout
Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T Lymphocytes to Recipients of Mismatched-Related or Phenotypically Similar Unrelated Donor Marrow Grafts. St. Jude Children's Research Hospital, Memphis, Tennesse
1994
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
1998 Standout
Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
1998
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells After Breast Cancer Chemotherapy
1999
Retroviral-mediated gene correction for X-linked severe combined immunodeficiency
1996
Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow
1994
Identification of Human and Mouse Hematopoietic Stem Cell Populations Expressing High Levels of mRNA Encoding Retrovirus Receptors
1998
Chemokines
1997 Standout
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient Patients
1995 Science
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
2000 StandoutScience
Quantum Dot-Based Multiplexed Fluorescence Resonance Energy Transfer
2005 StandoutNobel
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
2001 Standout
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma
1995
Cytokine-Facilitated Transduction Leads to Low-Level Engraftment in Nonablated Hosts
1997
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma
1994
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Transfer of Genes to Humans: Early Lessons and Obstacles to Success
1995 Science
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation
2000 StandoutNobel
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells
2000
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
2001 Standout
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Immunobiology of Dendritic Cells
2000 Standout
The Biology of Chemokines and their Receptors
2000 Standout
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
1998
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
1998
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
1993
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
2000 Standout
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice.
1996
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations
1995
NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
2002 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of D. Rill being referenced
Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow Transplantation
1992
Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication
1993
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
1993
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients
1993
Gene Transfer and Bone Marrow Transplantation
1994
An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer
1992